AR and posterior cortical atrophy: In this study, we show for the first time that combination of miR-99b-5p mimic and second-generation AR antagonist (such as enzalutamide or abiraterone) simultaneously targets AR and mTOR signaling, consequently inhibiting epithelial-mesenchymal transition (EMT) in PCa.